Two Hundred Forty Minimally Invasive Mitral Operations Through Right Minithoracotomy

Aybek, Tayfun; Doğan, Selami; Risteski, Petar; Zierer, Andreas; Wittlinger, Thomas; Wimmer‐Greinecker, Gerhard; Moritz, Anton

doi:10.1016/j.athoracsur.2005.12.006

Cited by 80 publications

(48 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a study, El-Fiky et al (2000)observed that the mean age of study population was 22 ± 10 years, which is comparable with the current study. 9 However, Ganie et al (2013) and Aybek et al (2006) found the mean age was 44.4 ± 8.2 and 56 ± 14 years respectively in right anterolateral thoracotomy, which is higher with the current study. 6, 11 Similarly, in another study Grossiet al was found the mean age 55.3 ± 17.2 years in standard sternotomy approach, which also higher with the current study.…”

Section: Discussioncontrasting

confidence: 50%

Early outcome of mitral valve replacement through right anterolateral thoracotomy versus standard median sternotomy

Saha

Ranjan

Adhikary

et al. 2018

Bangabandhu Sheikh Mujib Medical University Journal

View full text Add to dashboard Cite

<p class="Abstract">This study was aimed to compare the peri-operative outcomes among the mitral valve replace-ment using anterolateral thoracotomy (n=17) and standard median sternotomy (n=17) in a single surgeons practice. The mean age was 24.1 ± 5.3 years in Group I and 41.0 ± 11.5 years in Group II. Female was predominant in Group I. Total operative time and bypass time were significant in both the study groups. Incision scar was not visible in females in Group I but full incision scar was visible in Group II in sitting posture. In Group I patients, majority (52.9%) patients needed short duration of ICU stay in comparison to Group II, and the difference was statistically significant (p<0.05) between the two groups. During discharge, 94.1% wound was well healed in Group I and 70.6% in Group II. Wound dehiscence was nil in Group I, but 23.5% patients developed dehiscence in Group II. However, only 5.9% patient developed unstable sternum in Group II. Cosmetic mitral valve replacement can be done safely through anterolateral thoracotomy and it is cost effective especially for the developing countries.</p>

show abstract

Section: Discussioncontrasting

confidence: 50%

Early outcome of mitral valve replacement through right anterolateral thoracotomy versus standard median sternotomy

Saha

Ranjan

Adhikary

et al. 2018

Bangabandhu Sheikh Mujib Medical University Journal

View full text Add to dashboard Cite

show abstract

“…We compared the results to the currently available literature on isolated mitral valve surgery either minimally invasively or through full sternotomy [1,2,4,[8][9][10][11][12][13][14][15][16][17][18][19]. Mortality rates reported were anywhere between 0.2 for elective mitral valve repair [19] to 11.6% for valve replacement [9] versus an observed mortality rate of 1.4% in the current analysis including valve replacement, combined and reoperative cases.…”

Section: Literature Comparisonmentioning

confidence: 97%

Endoaortic Clamping Does Not Increase the Risk of Stroke in Minimal Access Mitral Valve Surgery: A Multicenter Experience

Casselman¹,

Aramendi²,

Bentala³

et al. 2015

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

Background. Some controversy exists regarding the safety of endoaortic balloon clamping in minimal access isolated mitral valve surgery (MIMVS). The aim of this European multicenter study was to analyze the results in 10 experienced centers and compare the outcomes with published data.Methods. The most recent 50 consecutive MIMVS cases from10 European surgeons who had performed at least 100 procedures were prospectively collected and retrospectively analyzed. All procedures were performed through right minithoracotomy with femoral cannulation and endoaortic balloon occlusion. In-hospital and 30-day outcomes were studied. Mortality and stroke rates were compared with published median sternotomy and MIMVS outcomes.Results. Mean age was 63.2 ± 12.5 years, 289 (57.8%) were male, mean logistic European system for cardiac operative risk evaluation was 6.1 ± 6.2, and 53 (10.6%) procedures had cardiac reoperations. Concomitant procedures were performed in 126 (25.9%) cases. Three patients (0.6%) required conversion to full sternotomy. Ten patients (2.0%) necessitated endoaortic balloon clamping conversion (8 to external clamping), and

show abstract

“…They concluded that a mini-sternotomy can be performed safely for aortic valve replacement without an increased risk of death, major complications (Khoshbin et al, 2011), a reduction in ICU stay time (Brown et al, 2009), or clinical benefit (Aybek et al, 2000). Moreover, we excluded 12 studies because they had no control groups (Loulmet et al, 1998;Mishra et al, 1999;Riess et al, 2001;Grossi et al, 2002;Onnasch et al, 2002b;Aybek et al, 2006;Martin et al, 2006;Seeburger et al, 2008;Glaubera et al, 2009;Müller et al, 2011;Reser et al, 2012), which ranged from 22 to 1339 in sample size. However, these studies, with 3085 patients in total, summarized the long-term clinical experience of ALMT, which is useful for making clinical decisions and ensuring the safety of ALMT.…”

Section: Discussionmentioning

confidence: 99%

Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis

Ding

Jiang

Tao

et al. 2014

J. Zhejiang Univ. Sci. B

View full text Add to dashboard Cite

Abstract:Objective: Mitral valve disease tends to be treated with anterolateral minithoracotomy (ALMT) rather than median sternotomy (MS), as ALMT uses progressively smaller incisions to promote better cosmetic outcomes. This meta-analysis quantifies the effects of ALMT on surgical parameters and post-operative outcomes compared with MS. Methods: One randomized controlled study and four case-control studies, published in English from January 1996 to January 2013, were identified and evaluated. Results: ALMT showed a significantly longer cardiopulmonary bypass time (P=0.001) and aortic cross-clamp time (P=0.05) compared with MS. However, the benefits of ALMT were evident as demonstrated by a shorter length of hospital stay (P<0.00001). According to operative complications, the onset of new arrhythmias following ALMT decreased significantly as compared with MS (P=0.05); however, the incidence of peri-operative mortality (P=0.62), re-operation for bleeding (P=0.37), neurologic events (P=0.77), myocardial infarction (P=0.84), gastrointestinal complications (P=0.89), and renal insufficiency (P=0.67) were similar to these of MS. Long-term follow-up data were also examined, and revealed equivalent survival and freedom from mitral valve events. Conclusions: Current clinical data suggest that ALMT is a safe and effective alternative to the conventional approach and is associated with better short-term outcomes and a trend towards longer survival.

show abstract

Two Hundred Forty Minimally Invasive Mitral Operations Through Right Minithoracotomy

Cited by 80 publications

References 23 publications

Early outcome of mitral valve replacement through right anterolateral thoracotomy versus standard median sternotomy

Early outcome of mitral valve replacement through right anterolateral thoracotomy versus standard median sternotomy

Endoaortic Clamping Does Not Increase the Risk of Stroke in Minimal Access Mitral Valve Surgery: A Multicenter Experience

Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis

Contact Info

Product

Resources

About